08 April 2025 : Original article
Long-Term Outcomes of Left Renal Vein Ligation in Living Donor Liver Transplantation: A 20-Year Study
Hyo Jung KoDOI: 10.12659/AOT.947492
Ann Transplant 2025; 30:e947492
Table 1 Patient demographics.
| Parameters | Values | |
|---|---|---|
| Sex (n) | Male: Female | 31: 13 |
| Age (years) | 51.2±7.8 (range: 26–64) | |
| Primary diagnosis (n) | HBV | 40 (90.9%) |
| HCV | 2 (4.6%) | |
| PSC | 2 (4.6%) | |
| Concurrent HCC (n) | 7 (15.9%) | |
| MELD score | 19.5±8.1 (range: 6–40) | |
| Graft type (n) | Right liver | 19 (43.2%) |
| Left liver | 7 (15.9%) | |
| Dual graft | 18 (40.9%) | |
| GRWR | 0.97±0.19 (range: 0.49–1.45) | |
| Pre-transplant morphometry | SSRS diameter at LRV insertion (mm) | 17.3±5.9 (range: 10–30) |
| Main PV trunk diameter (mm) | 9.2±3.3 (range: 3.7–16.0) | |
| HBV – hepatitis B virus; HCV – hepatitis C virus; PSC – primary sclerosing cholangitis; HCC – hepatocellular carcinoma; MELD – model for end-stage liver disease; GRWR – graft-to-recipient weight ratio; SSRS – spontaneous splenorenal shunt; LRV – left renal vein; PV – portal vein. | ||






